scholarly article | Q13442814 |
P2093 | author name string | Robert Freedman | |
Jason R Tregellas | |||
Jody Tanabe | |||
Laura F Martin | |||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | schizophrenia | Q41112 |
nicotine | Q12144 | ||
P304 | page(s) | 754-761 | |
P577 | publication date | 2005-11-02 | |
P1433 | published in | Biological Psychiatry | Q4914961 |
P1476 | title | Effects of nicotine on hippocampal and cingulate activity during smooth pursuit eye movement in schizophrenia | |
P478 | volume | 59 |
Q37962995 | A review of neurobiological vulnerability factors and treatment implications for comorbid tobacco dependence in schizophrenia |
Q48267104 | Altered parahippocampal functioning in cannabis users is related to the frequency of use. |
Q36756379 | Cholinergic circuits and signaling in the pathophysiology of schizophrenia |
Q38124448 | Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings |
Q35211484 | Could vagus nerve stimulation target hippocampal hyperactivity to improve cognition in schizophrenia? |
Q35539209 | Eye tracking dysfunction in schizophrenia: characterization and pathophysiology |
Q28394799 | Functional magnetic resonance imaging of semantic memory as a presymptomatic biomarker of Alzheimer's disease risk |
Q90394165 | Generalizability of machine learning for classification of schizophrenia based on resting-state functional MRI data |
Q38171876 | Going up in smoke? A review of nAChRs-based treatment strategies for improving cognition in schizophrenia |
Q60046151 | Neurobiological Determinants of Tobacco Smoking in Schizophrenia |
Q33503660 | Neuroimaging of Nicotine Dependence: Key Findings and Application to the Study of Smoking-Mental Illness Comorbidity |
Q37010016 | Neuroimaging, genetics and the treatment of nicotine addiction |
Q35589463 | Neuronal effects of nicotine during auditory selective attention |
Q30366764 | Neuronal effects of nicotine during auditory selective attention in schizophrenia |
Q37059455 | Nicotine and nicotinic system in hypoglutamatergic models of schizophrenia |
Q42122993 | Nicotine restores functional connectivity of the ventral attention network in schizophrenia |
Q37294509 | Nicotine self-medication of cognitive-attentional processing |
Q36564840 | Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms |
Q35173870 | Pharmacological treatment effects on eye movement control |
Q30483462 | Proline affects brain function in 22q11DS children with the low activity COMT 158 allele |
Q36474143 | Smoking cessation in patients with psychiatric disorders |
Q30491841 | Smoking, Genetics and Schizophrenia: Evidence for Self Medication |
Q30366697 | Targeting Functional Biomarkers in Schizophrenia with Neuroimaging. |
Q33724801 | The effects of galantamine on psychopathology in chronic stable schizophrenia |
Q91908590 | The relationship between nicotine and psychosis |
Q51984624 | [Electrophysiologic endophenotype in schizophrenia]. |
Search more.